ROS1 + non-small cell lung cancers (NSCLC) account for 2% of newly diagnosed cases, arising as a result of a chromosomal translocation that leads to the formation of an oncogenic fusion protein [1]. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.